Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
Eli Lilly and Company
AstraZeneca
Kivu Bioscience Inc.
NeoImmuneTech
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Sichuan Enray Pharmaceutical Sciences Company
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
M.D. Anderson Cancer Center
Arvinas Inc.
Essen Biotech
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Eli Lilly and Company
Poseida Therapeutics, Inc.
MacroGenics
Unity Health Toronto
Daiichi Sankyo
SN BioScience
Cue Biopharma
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
Eli Lilly and Company
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
MOMA Therapeutics
Mayo Clinic
City of Hope Medical Center
Washington University School of Medicine
Alaunos Therapeutics
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
GE Healthcare
Actym Therapeutics, Inc.